Point72 Middle East FZE »

Design Therapeutics shares owned by Point72 Middle East FZE

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Point72 Middle East FZE from 13F filings

Historical chart of Point72 Middle East FZE investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Point72 Middle East FZE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Point72 Middle East FZE

Quarter filed Position value Share count Share price at filing
2023-12-31 $25k 9.4k 2.65
2023-09-30 $12k 4.9k 2.36
2023-06-30 $57k 9.1k 6.30
2023-03-31 $54k 9.4k 5.77

More positions owned by Point72 Middle East FZE

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
General Motors Company (GM)
Eli Lilly & Co. (LLY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Caterpillar Call Option (CAT)
UnitedHealth (UNH)
Amazon (AMZN)
Jd.com Spon Adr Cl A (JD)
Lauder Estee Cos Cl A Call Option (EL)
Target Corporation Call Option (TGT)
At&t (T)
Analog Devices Call Option (ADI)
Synopsys (SNPS)

View all positions for Point72 Middle East FZE

Top funds holding Design Therapeutics

Sr One Capital Management
Logos Global Management
Citadel Advisors
Baker Bros. Advisors
Tang Capital Management
Almitas Capital
Goldman Sachs Group
Vanguard Group
BML Capital Management
Two Sigma Advisers
Jacobs Levy Equity Management
Two Sigma Investments
Millennium Management
Walleye Trading Advisors
Assenagon Asset Management

View all funds holding Design Therapeutics